Longitudinal Assessment of Antipneumococcal Susceptibility in the United States
The prevalence of antimicrobial resistance among 4,940 U.S. pneumococcal isolates collected during 1999 was as follows: penicillin, 16.2%; amoxicillin-clavulanate, 12.2%; cefuroxime, 28.1%; ceftriaxone, 3.6%; trimethoprim-sulfamethoxazole, 30.3%; azithromycin, 21.4%; levofloxacin, 0.6%; and moxiflox...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
2002
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127351/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12121949/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.8.2651-2655.2002 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
